The Risk Of Thromboembolic Events In COVID-19 Patients During The Height Of The SARS-CoV-2 Pandemic

COVID-19 is associated with a prothrombotic state and elevated risk of thromboembolism. This study assesses the risk of thromboembolic events and their impact on hospitalization of COVID-19 inpatients.▪▪▪ Retrospective review of all COVID-19 inpatients (≥18 years old) at a single academic institution from March 15, 2020 - July 1, 2020 was performed. Patient data included demographics, comorbidities, hospital admission type, thromboembolic events, laboratory values, use of anticoagulants/antiplatelets, hospital length of stay, and mortality. Within 826 COVID-19 inpatients (56% male, 44% female) identified, 87 patients (10.5%) had 98 thromboembolic events. (Table 1). Hypertension, CAD, and CLTI were associated with increased incidence of thromboembolism (p